Health and cost impact of stepping down asthma medication for UK patients, 2001-2017: A population-based observational study.

Chloe I Bloom Dr Laure de PreuxAziz SheikhJennifer Kathleen Quint

Published in: PLoS medicine (2020)

In this UK study, we observed that asthma patients were increasingly prescribed higher levels of treatment, often without clear clinical indication for such high doses. Stepping down medication did not adversely affect outcomes and was associated with substantial cost savings.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
chronic obstructive pulmonary disease
peritoneal dialysis
public health
prognostic factors
emergency department
lung function
type diabetes
climate change
cross sectional
adverse drug
electronic health record
glycemic control